Small Intestinal Bacterial Overgrowth: A Prospective Registry

N/AEnrolling By InvitationNCT01822470

Indiana University200 enrolled

Overview

The purpose of this study is to investigate the prevalence of small intestinal bacterial overgrowth (SIBO) in patients who will be undergoing an enteroscopy as an outpatient procedure with symptoms of functional dyspepsia. In addition, the investigators would like to identify the types of bacteria that are present in the small intestines in patients with SIBO and compare two different diagnostic tools: microbiologic culture and DNA sequencing of bacteria. The aim is to compare the microbiota between patients with and without the clinical complications of SIBO

Same as above

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Functional Dyspepsia Small Intestinal Bacterial Overgrowth

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

1.Study Subjects Inclusion Criteria i. All patients who are undergoing small bowel aspiration for suspected SIBO regardless etiology. Exclusion Criteria i. Use of colon cleansing prep in the past 1 month ii. Treatment with antibiotics in the past 30 days (antibiotics are allowable for patients undergoing clinical indicated repeat aspiration to determine bacteria clearance) iii. Use of probiotics in the past 30 days iv. Contraindication for upper endoscopy for any reason v. Prisoners vi. Pregnant vii. Unable to give own informed consent 2 Control Subjects Inclusion Criteria i. Patients who are undergoing double balloon enteroscopy or upper enteroscopy for another medical reason. Exclusion Criteria i. Diagnosis of SIBO ii. Diagnosis of functional dyspepsia iii. Established risk factors for SIBO (ANY of the following) 1. Connective tissue disorder (scleroderma, polymyositis, mixed connective tissue disease, or systemic lupus 2. Resection of ileocecal valve for any reason 3. Chronic intestinal pseudo-obstruction 4. Small bowel blind limb, diverticulum or fistula 5. Surgery with decreased gastric acid exposure for small bowel a. Gastric surgery with vagotomy (Bilroth I, Bilroth II, vagotomy/pyloroplasty) or gastric bypass iv. Use of colon cleansing prep in the past 1 month v. Use of antibiotics in the past 30 days vi. Use of probiotics in the past 30 days vii. Contraindication for upper endoscopy for any reason viii. Prisoners ix. Pregnant x. Unable to give own informed

Outcomes

Primary Outcomes

To determine the predictors for SIBO in patients with functional dyspepsia, who do not have the established risk factors for SIBO

In this population, prevalence of potential predictors of SIBO will be compared between subjects with and without a diagnosis of Gram Negative Bacteria SIBO

Time frame: two years

Secondary Outcomes

A registry of patients undergoing proximal jejunal aspiration for suspected small intestinal bacterial overgrowth

A prospective registry will be created for all subjects who are undergoing jejunal aspirate for clinical indications. Private health information will be excluded from the data registry. Data collected for the registry will include: 1. Demographics 2. Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index total and subscale scores 3. Presence of functional gastrointestinal disorders 4. Established risk factors of gram negative small intestinal bacterial overgrowth. 5. Established risk factors of upper respiratory tract small intestinal bacterial overgrowth

Time frame: Two years

The demographics, clinical history, and symptoms in patients with and without SIBO

Demographics 2. Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index total and subscale scores 3. Presence of functional gastrointestinal disorders 4. Established risk factors of gram negative small intestinal bacterial overgrowth. 5\. Established risk factors of upper respiratory tract small intestinal bacterial overgrowth

Time frame: One day

Characterize the clinical differences between small intestinal bacterial overgrowth by upper respiratory tract bacteria and small intestinal bacterial overgrowth by gram-negative bacilli bacteria

clinical differences between small intestinal bacterial overgrowth by upper respiratory tract bacteria

Time frame: One day

Compare the composition between luminal and mucosal bacteria in the proximal small bowel

Compare the results of bacteria species isolated from molecular polymerase chain reaction identification between luminal aspiration samples and mucosa biopsy samples.

Time frame: One day

Small Intestinal Bacterial Overgrowth: A Prospective Registry

Overview

Conditions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes